寻求戒毒治疗的阿片类药物依赖成年人中的HIV风险行为：海洛因和羟考酮使用者的探索性比较
HIV risk behavior in opioid dependent adults seeking detoxification treatment: an exploratory comparison of heroin and oxycodone users.
作者信息
Meade Christina S, McDonald Leah J, Weiss Roger D
机构信息
McLean Hospital and Harvard Medical School, Belmont, Massachusetts, USA.
出版信息
Am J Addict. 2009 Jul-Aug;18(4):289-93. doi: 10.1080/10550490902925821.
Abstract
Heroin users are at high risk for HIV infection, but little is known about HIV risk in oxycodone users. This study examined HIV risk behaviors in heroin (n = 27) and oxycodone (n = 23) users seeking inpatient detoxification at a private psychiatric hospital. Drug use histories were similar, except oxycodone users used marijuana more frequently. Injection drug risk occurred exclusively among heroin users. The rates of sexual activity (66%), unprotected intercourse (69%), sex while intoxicated (74%), and sex with strangers (24%) were similar, but more oxycodone users had multiple partners (39% vs. 6%, p < .05). HIV prevention efforts should target both heroin and oxycodone users.
摘要
海洛因使用者感染艾滋病毒的风险很高，但对于羟考酮使用者的艾滋病毒风险却知之甚少。本研究调查了在一家私立精神病医院寻求住院戒毒的海洛因使用者（n = 27）和羟考酮使用者（n = 23）的艾滋病毒风险行为。除了羟考酮使用者更频繁地使用大麻外，他们的吸毒史相似。注射毒品风险仅发生在海洛因使用者中。性行为发生率（66%）、无保护性行为发生率（69%）、醉酒时性行为发生率（74%）和与陌生人发生性行为发生率（24%）相似，但更多的羟考酮使用者有多个性伴侣（39%对6%，p < 0.05）。艾滋病毒预防工作应针对海洛因和羟考酮使用者。
相似文献
1
HIV risk behavior in opioid dependent adults seeking detoxification treatment: an exploratory comparison of heroin and oxycodone users.
Am J Addict. 2009 Jul-Aug;18(4):289-93. doi: 10.1080/10550490902925821.
2
Prevalence of psychotic symptoms in substance users: a comparison across substances.
Compr Psychiatry. 2009 May-Jun;50(3):245-50. doi: 10.1016/j.comppsych.2008.07.009. Epub 2008 Sep 23.
3
How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
J Addict Med. 2011 Mar;5(1):28-35. doi: 10.1097/ADM.0b013e3181e0364e.
4
Event-level analyses of sex-risk and injection-risk behaviors among nonmedical prescription opioid users.
Am J Drug Alcohol Abuse. 2016 Nov;42(6):689-697. doi: 10.1080/00952990.2016.1174706. Epub 2016 Jun 10.
5
Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder.
Drug Alcohol Depend. 2009 Apr 1;101(1-2):13-9. doi: 10.1016/j.drugalcdep.2008.10.015. Epub 2008 Dec 9.
6
HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
MMWR Surveill Summ. 2014 Jul 4;63(6):1-51.
7
Injecting, sexual risk behaviors and HIV infection in young cocaine and heroin users in Spain.
Eur Addict Res. 2009;15(3):171-8. doi: 10.1159/000220345. Epub 2009 Jun 5.
8
Multilevel analysis of HIV related risk behaviors among heroin users in a low prevalence community.
BMC Public Health. 2009 May 12;9:137. doi: 10.1186/1471-2458-9-137.
9
Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City.
J Subst Abuse Treat. 2015 Jan;48(1):13-20. doi: 10.1016/j.jsat.2014.07.002. Epub 2014 Jul 11.
10
Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
JAMA. 2000 Mar 8;283(10):1303-10. doi: 10.1001/jama.283.10.1303.
引用本文的文献
1
HIV risk perception, pre-exposure prophylaxis (PrEP) awareness, and PrEP initiation intention among women who use drugs.
J Subst Use Addict Treat. 2023 Sep;152:209119. doi: 10.1016/j.josat.2023.209119. Epub 2023 Jul 13.
2
A pilot study investigating cognitive impairment associated with opioid overdose.
Drug Alcohol Depend. 2023 Jun 1;247:109865. doi: 10.1016/j.drugalcdep.2023.109865. Epub 2023 Apr 5.
3
Healthcare stigma and HIV risk among rural people who inject drugs.
Drug Alcohol Depend. 2021 Sep 1;226:108878. doi: 10.1016/j.drugalcdep.2021.108878. Epub 2021 Jun 25.
4
Risky Sexual Behavior Among Individuals Receiving Buprenorphine/Naloxone Opiate Dependency Treatment: HIV Prevention Trials Network (HPTN) 058.
J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):300-307. doi: 10.1097/QAI.0000000000001683.
5
Alternate Routes of Administration among Prescription Opioid Misusers and Associations with Sexual HIV Transmission Risk Behaviors.
J Psychoactive Drugs. 2016 Jul-Aug;48(3):187-94. doi: 10.1080/02791072.2016.1187319. Epub 2016 May 25.
6
Neurocognitive, psychiatric, and substance use characteristics in opioid dependent adults.
Addict Behav. 2016 Sep;60:137-43. doi: 10.1016/j.addbeh.2016.03.018. Epub 2016 Mar 31.
7
Co-relationship between sexual dysfunction and high-risk sexual behavior in patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence.
Ind Psychiatry J. 2015 Jan-Jun;24(1):29-34. doi: 10.4103/0972-6748.160930.
8
Data Sources Regarding the Nonmedical Use of Pharmaceutical Opioids in the United States.
Rev Health Care. 2014;5(1):33-50. doi: 10.7175/rhc.v5i1.883.
9
Nonmedical prescription drug users in private vs. public substance abuse treatment: a cross sectional comparison of demographic and HIV risk behavior profiles.
Subst Abuse Treat Prev Policy. 2014 Feb 4;9:9. doi: 10.1186/1747-597X-9-9.
10
The Age of Initiation of Drug Use and Sexual Behavior May Influence Subsequent HIV Risk Behavior: A Systematic Review.
ISRN AIDS. 2013 Dec 7;2013:976035. doi: 10.1155/2013/976035.
本文引用的文献
1
Sexual uses of alcohol and drugs and the associated health risks: a cross sectional study of young people in nine European cities.
BMC Public Health. 2008 May 9;8:155. doi: 10.1186/1471-2458-8-155.
2
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors.
J Subst Abuse Treat. 2008 Jul;35(1):87-92. doi: 10.1016/j.jsat.2007.08.004. Epub 2007 Oct 15.
3
A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs).
Am J Drug Alcohol Abuse. 2007;33(4):527-36. doi: 10.1080/00952990701407397.
4
Illicit use of opioids: is OxyContin a "gateway drug"?
Am J Addict. 2007 May-Jun;16(3):166-73. doi: 10.1080/10550490701375293.
5
Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
AIDS. 2007 Jan 11;21(2):231-5. doi: 10.1097/QAD.0b013e3280114a15.
6
Characterizing the emerging population of prescription opioid abusers.
Am J Addict. 2006 May-Jun;15(3):208-12. doi: 10.1080/10550490600625624.
7
HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.
J Subst Abuse Treat. 2006 Sep;31(2):187-94. doi: 10.1016/j.jsat.2006.04.005. Epub 2006 Jul 18.
8
Association between cannabis use and sexual risk behavior among young heterosexual adults.
AIDS Behav. 2006 Sep;10(5):599-605. doi: 10.1007/s10461-006-9103-9.
9
Prevention interventions with persons living with HIV/AIDS: state of the science and future directions.
AIDS Educ Prev. 2005 Feb;17(1 Suppl A):6-20. doi: 10.1521/aeap.17.2.6.58697.
10
Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing.
Drug Alcohol Depend. 2005 Feb 14;77(2):195-204. doi: 10.1016/j.drugalcdep.2004.08.011.
Zotero 插件